Archive Newsletter

31. 08.03.20 -- Considerations In Drug Development: Reduce Cost, Improve Success Rate, And Shorten Time To Market 8/3/2020
    08/03/20 Cell & Gene Newsletter
32. 07.29.20 -- Quality By Design In Gene Therapy Manufacturing 7/29/2020
    07/29/20 Cell & Gene Newsletter
33. 07.28.20 -- How NJIT Is Tackling CGT Development, Manufacturing 7/28/2020
    07/28/20 Cell & Gene Newsletter
34. 07.27.20 -- Choosing The Best Sterile Dosage Forms For Your Phase I Clinical Supply Needs 7/27/2020
    07/27/20 Cell & Gene Newsletter
35. 07.23.20 -- How Technology And Data Are Impacting Your Organization's Clinical Development 7/23/2020
    07/23/20 Cell & Gene Newsletter
36. 07.22.20 -- Meet Increased Performance And Scale For COVID-19 Bioprocessing 7/22/2020
    07/22/20 Cell & Gene Newsletter
37. 07.21.20 -- A Strategic Approach To Efficient Drug Development 7/21/2020
    07/21/20 Cell & Gene Newsletter
38. 07.21.20 -- Surviving A Virtual Regulatory Inspection During COVID-19 7/21/2020
    07/21/20 Cell & Gene Newsletter
39. 07.20.20 -- Considerations For End-To-End Temperature Measurement In The Clinical Supply Chain 7/20/2020
    07/20/20 Cell & Gene Newsletter
40. 07.16.20 -- Updates From Thermo Fisher Scientific 7/16/2020
    07/16/20 Cell & Gene Newsletter